#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.MedicalEntity|DCT|MedicalEntity
#T_RL=webanno.custom.TLINK|TLINK|BT_webanno.custom.MedicalEntity


#Text=02.03.2023:
#Text=Kvinne 36 år med uttalt fatigue siste 8 måneder etter mononukleose.
1-1	0-10	02.03.2023	_	_	_	_	
1-2	10-11	:	_	_	_	_	
1-3	12-18	Kvinne	_	_	_	_	
1-4	19-21	36	_	_	_	_	
1-5	22-24	år	_	_	_	_	
1-6	25-28	med	_	_	_	_	
1-7	29-35	uttalt	_	_	_	_	
1-8	36-43	fatigue	BEFOREOVERLAP	CONDITION	_	_	
1-9	44-49	siste	_	_	_	_	
1-10	50-51	8	_	_	_	_	
1-11	52-59	måneder	_	_	_	_	
1-12	60-65	etter	_	_	_	_	
1-13	66-78	mononukleose	BEFORE	CONDITION	_	_	
1-14	78-79	.	_	_	_	_	

#Text=PEM (post-exertional malaise) fremtredende.
2-1	80-83	PEM	OVERLAP[1]	CONDITION[1]	_	_	
2-2	84-85	(	OVERLAP[1]	CONDITION[1]	_	_	
2-3	85-100	post-exertional	OVERLAP[1]	CONDITION[1]	_	_	
2-4	101-108	malaise	OVERLAP[1]	CONDITION[1]	_	_	
2-5	108-109	)	OVERLAP[1]	CONDITION[1]	_	_	
2-6	110-122	fremtredende	_	_	_	_	
2-7	122-123	.	_	_	_	_	

#Text=Kognitive vansker, søvnforstyrrelser.
3-1	124-133	Kognitive	OVERLAP[2]	CONDITION[2]	_	_	
3-2	134-141	vansker	OVERLAP[2]	CONDITION[2]	_	_	
3-3	141-142	,	_	_	_	_	
3-4	143-160	søvnforstyrrelser	OVERLAP	CONDITION	OVERLAP	3-1[2_0]	
3-5	160-161	.	_	_	_	_	

#Text=Normal somatisk status.
4-1	162-168	Normal	OVERLAP[3]	CONDITION[3]	_	_	
4-2	169-177	somatisk	OVERLAP[3]	CONDITION[3]	_	_	
4-3	178-184	status	OVERLAP[3]	CONDITION[3]	_	_	
4-4	184-185	.	_	_	_	_	

#Text=Omfattende blodprøver normale.
5-1	186-196	Omfattende	OVERLAP[4]	CONDITION[4]	OVERLAP	4-1[3_4]	
5-2	197-207	blodprøver	OVERLAP[4]	CONDITION[4]	_	_	
5-3	208-215	normale	OVERLAP[4]	CONDITION[4]	_	_	
5-4	215-216	.	_	_	_	_	

#Text=Oppfyller Canada-kriteriene for ME/CFS.
6-1	217-226	Oppfyller	_	_	_	_	
6-2	227-244	Canada-kriteriene	_	_	_	_	
6-3	245-248	for	_	_	_	_	
6-4	249-251	ME	_	_	_	_	
6-5	251-252	/	_	_	_	_	
6-6	252-255	CFS	_	_	_	_	
6-7	255-256	.	_	_	_	_	

#Text=Henviser ME/CFS-team.
7-1	257-265	Henviser	AFTER[5]	TREATMENT[5]	_	_	
7-2	266-268	ME	AFTER[5]	TREATMENT[5]	_	_	
7-3	268-269	/	AFTER[5]	TREATMENT[5]	_	_	
7-4	269-277	CFS-team	AFTER[5]	TREATMENT[5]	_	_	
7-5	277-278	.	_	_	_	_	
